R&D Partner Content 2nd LNP Immunogenicity & Toxicity Summit Back for its second iteration, the LNP Immunogenicity & Toxicity Summit (December 11-13, 2023 | Boston) will bring together 1
Views & Analysis Overcoming the challenges of developing vaccines in an accel... The COVID-19 pandemic stopped the world in its tracks.
Events Partner Content 2nd Gene Therapy Immunogenicity Modulate, Measure & Predict Immune Response to GTx
Partner Content Partner Content A Run Down of Keynote Sessions for Cell & Gene Therapy 2... Cell and Gene Therapy
Partner Content Partner Content Immuno-Oncology challenges include identifying patients befo... Challenges facing Immuno-Oncology industry
Events Partner Content SMi's 5th Annual Biosimilars USA Conference Biosimilars USA conference information
News In shock move, EU panel rejects Alzheimer's drug Leqembi The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh
Sales & Marketing Sponsored How doctors are interacting with content in 10 data trends It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.